RUO‘ZENLog in
Stocks › Healthcare › VRTX

Vertex stockVRTX

Vertex Pharmaceuticals Inc · Nasdaq · also searched as: vertex
$542.50
−1.19% on the day
close Nov 5, 2026
What is happening with the stock

Vertex trades at $542.50, 4.6% below its 52-week high (Nov 2, 2026). The price is above its 50- and 200-day averages, i.e. in an uptrend. +19.7% year to date, +30.1% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Feb 9, 2027.

Closing price, 6 monthsdetailed chart in the terminal
41749557452-week high 568.67May 8, 2026Nov 5, 2026
Reported figurestrailing 12 months
🔒 Sector comparison, estimates and ratings are in the terminal

Ratings, candles, signals and the screener for VRTX — after you log in

Open the terminal
From 52-week high−4.6%
High568.67 Nov 2, 2026
vs 50-day avg+3.8%
vs 200-day avg+12.7%
Year to date+19.7%
12 months+30.1%
P/E28.6
Dividend yieldnone
EarningsFeb 9
Market cap$137.5B
Chart patterncup without handle
Exchange · sinceNasdaq · 1991

Frequently asked questions about Vertex

What is the Vertex stock price?

At the close on Nov 5, 2026: $542.50 (−1.19% on the day). 52-week high: $568.67 on Nov 2, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.

When does Vertex report earnings?

The next quarterly report is on Feb 9, 2027. Last quarter, earnings per share changed −1% year over year, revenue +12%.

Does Vertex pay dividends?

No, Vertex does not pay dividends.

Where does Vertex trade and how to buy it?

Ticker VRTX, exchange Nasdaq, listed since 1991. You can buy it through a broker with access to US exchanges.

Should I buy Vertex now?

We do not give buy or sell advice. Ratings, the detailed chart and signals for VRTX are in the terminal after you log in.

Similar stocks

More on VRTX

Included in lists